RECURRENT UTERINE CORPUS CARCINOMA
Clinical trials for RECURRENT UTERINE CORPUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT UTERINE CORPUS CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT UTERINE CORPUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Hard-to-Treat recurrent cancers
Disease control OngoingThis early-phase trial studies two drug combinations (olaparib plus vistusertib or olaparib plus capivasertib) in people with recurrent endometrial, triple-negative breast, ovarian, or related cancers. The main goal is to find the safest dose and understand side effects. About 15…
Matched conditions: RECURRENT UTERINE CORPUS CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:26 UTC
-
Heated chemo during surgery shows promise for Tough-to-Treat ovarian cancer
Disease control OngoingThis early-phase study tests whether giving a dose of heated chemotherapy directly into the abdomen during surgery can help lower the risk of cancer returning in people with advanced ovarian, fallopian tube, uterine, or peritoneal cancer. About 40 participants with stage III or I…
Matched conditions: RECURRENT UTERINE CORPUS CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 18, 2026 12:02 UTC